Anzeige
❌
Mehr »
Login
Donnerstag, 03.04.2025 Börsentäglich über 12.000 News von 695 internationalen Medien
Der CEO kauft ein - und das gleich zweimal: Startschuss für die nächste Kursrallye?
Anzeige

Indizes
Kurs
%		News
24 h / 7 T		Aufrufe
7 Tage

Aktien
Kurs
%		News
24 h / 7 T		Aufrufe
7 Tage

Xetra-Orderbuch

Fonds
Kurs
%

Devisen
Kurs
%

Rohstoffe
Kurs
%

Themen
Kurs
%

Erweiterte Suche

WKN: A2QR0E | ISIN: US2075231017 | Ticker-Symbol:
NASDAQ
02.04.25
21:59 Uhr
0,631 US-Dollar
0,000
0,00 %
Branche
Biotechnologie
Aktienmarkt
Sonstige
1-Jahres-Chart
CONNECT BIOPHARMA HOLDINGS LTD ADR Chart 1 Jahr
5-Tage-Chart
CONNECT BIOPHARMA HOLDINGS LTD ADR 5-Tage-Chart

Aktuelle News zur CONNECT BIOPHARMA Aktie

Aktienalarm. Jetzt kostenlos anmelden!

E-Mail
Aktivieren
  • Alle
  • Pressemitteilungen
  • Empfehlungen
  • Chartanalysen
  • Berichte
ZeitAktuelle Nachrichten
Sprache: Alle DE EN
LeserMedien
DiConnect Biopharma Reports Positive Type C Meeting With The FDA For Rademikibart230AFX NewsBEIJING (dpa-AFX) - Clinical-stage biopharmaceutical company Connect Biopharma Holdings Ltd. (CNTB) Tuesday announced positive feedback from its Type C meeting with the U.S. Food and Drug Administration...
► Artikel lesen
DiFDA greenlights Connect Biopharma's asthma and COPD trials4Investing.com
DiConnect Biopharma Holdings Limited: Connect Biopharma Announces Positive Type C Meeting with the FDA for Rademikibart101GlobeNewswire (Europe)- FDA aligned on plan to initiate parallel Phase 2 trials of rademikibart in patients with moderate-to-severe asthma or COPD experiencing an acute exacerbation - - Expect to initiate both trials in...
► Artikel lesen
DiConnect Biopharma stock holds $8 target, Buy rating at H.C. Wainwright2Investing.com
MoConnect Biopharma Holdings Limited: Connect Biopharma Reports 2024 Full-Year Financial Results and Provides Business Update229GlobeNewswire (Europe)Strengthened leadership team with key appointments, including Barry Quart, Pharm.D. as CEO, and David Szekeres as President, bringing deep clinical, regulatory, operational and strategic expertise...
► Artikel lesen
MoConnect Biopharma Holdings Ltd - 10-K, Annual Report2SEC Filings
MoConnect Biopharma Holdings Ltd - 8-K, Current Report1SEC Filings
FrConnect Biopharma faces Nasdaq delisting over share price2Investing.com
CONNECT BIOPHARMA Aktie jetzt für 0€ handeln
FrConnect Biopharma receives Nasdaq non-compliance notice1Seeking Alpha
FrConnect Biopharma Holdings Limited: Connect Biopharma Announces Receipt of Nasdaq Deficiency Notice Regarding Minimum Bid Price Requirement100GlobeNewswire (Europe)SAN DIEGO, March 28, 2025 (GLOBE NEWSWIRE) -- Connect Biopharma Holdings Limited (Nasdaq: CNTB) (Connect Biopharma or the Company), a clinical-stage biopharmaceutical company focused on transforming...
► Artikel lesen
28.12.24Connect Biopharma Holdings Limited (NASDAQ:CNTB) Short Interest Up 53.5% in December2MarketBeat
23.12.24Connect Biopharma Holdings Ltd - 6-K, Report of foreign issuer1SEC Filings
05.09.24Connect Biopharma Holdings Limited: Connect Biopharma Reports First Half 2024 Financial Results and Provides Business Update148GlobeNewswire (Europe)Announced new U.S.-based leadership with the appointment of Barry Quart, Pharm.D. as Chief Executive Officer (CEO) and David Szekeres as PresidentConnect's new management is currently evaluating the...
► Artikel lesen
13.06.24Connect Biopharma Holdings Limited: Connect Biopharma Announces Inducement Grants under Nasdaq Listing Rule 5635(c)(4)178GlobeNewswire (Europe)SAN DIEGO, CA and TAICANG, China, June 12, 2024 (GLOBE NEWSWIRE) -- Connect Biopharma Holdings Limited (Nasdaq: CNTB) (Connect or the Company), a U.S.-headquartered, global clinical-stage biopharmaceutical...
► Artikel lesen
12.06.24Connect Biopharma Holdings Limited: Connect Biopharma Announces New Leadership and Chair of the Board of Directors190GlobeNewswire (Europe)Industry leader Barry Quart, Pharm.D. appointed as Chief Executive Officer succeeding Zheng Wei, Ph.D., who will remain on the Board of Directors and serve as an advisor to assist with the transitionExperienced...
► Artikel lesen
16.04.24Connect Biopharma Holdings Limited: Connect Biopharma Reports Full Year 2023 Financial Results and Provides Business Update224GlobeNewswire (Europe)Reported two positive readouts for rademikibart, the Company's lead asset, from the Global Phase 2b trial in moderate-to-severe persistent asthma and from the China pivotal trial in moderate-to-severe...
► Artikel lesen
16 Nachrichten in den letzten 12 Monaten
Ich würde die Aktie auf Sicht von 6 Monaten
VerkaufenHaltenKaufen
■ Verkaufen
■ Halten
■ Kaufen